• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身抗体识别的去唾液酸糖蛋白受体上抗原位点的研究。

Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies.

作者信息

Hajoui O, Martin S, Alvarez F

机构信息

Service de Gastroentérologie, Hôpital Sainte-Justine, Université de Montréal, Quebec, Canada.

出版信息

Clin Exp Immunol. 1998 Sep;113(3):339-45. doi: 10.1046/j.1365-2249.1998.00673.x.

DOI:10.1046/j.1365-2249.1998.00673.x
PMID:9737660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1905050/
Abstract

The aim of this study was to identify the epitopes recognized by antibodies to the asialoglycoprotein receptor, a specific hepatocyte protein, from sera of patients with autoimmune hepatitis. An ELISA test was used to detect anti-asialoglycoprotein receptor antibodies in the sera of patients with autoimmune hepatitis. Positive sera were tested against the same antigen by slot blot, by Western blot and by immunoprecipitation of the untreated protein and following treatment with beta-mercaptoethanol (beta-ME) and endoglycosidase F. The mature, unglycosylated and partially glycosylated forms of the asialoglycoprotein receptor synthesized by HepG2 cells were tested against positive patients' sera, as well as the in vitro translated unglycosylated form of the H1 subunit of the receptor. Sera from patients with autoimmune hepatitis recognized equally the native form, as well as the beta-ME-modified form, but less well the deglycosylated form of the human mature receptor. No reactivity was found when these sera were tested against the denatured human protein. In addition, neither the unglycosylated H1 subunit nor any of the HepG2-synthesized asialoglycoprotein receptor forms bound to the antibodies. Altogether, these results show that anti-asialoglycoprotein receptor antibodies in the sera of patients with autoimmune hepatitis are directed against conformational structures of the mature hetero-oligomeric form of the human liver protein and that at least some epitopes were located on the extracellular domain of the antigen.

摘要

本研究的目的是从自身免疫性肝炎患者的血清中鉴定出与去唾液酸糖蛋白受体(一种特异性肝细胞蛋白)抗体识别的表位。采用酶联免疫吸附测定(ELISA)检测自身免疫性肝炎患者血清中的抗去唾液酸糖蛋白受体抗体。通过狭缝印迹、蛋白质印迹以及对未处理的蛋白质、经β-巯基乙醇(β-ME)处理的蛋白质和经内切糖苷酶F处理的蛋白质进行免疫沉淀,对阳性血清进行相同抗原检测。用HepG2细胞合成的去唾液酸糖蛋白受体的成熟、未糖基化和部分糖基化形式,以及该受体H1亚基的体外翻译未糖基化形式检测阳性患者血清。自身免疫性肝炎患者的血清对人成熟受体的天然形式以及β-ME修饰形式的识别程度相同,但对去糖基化形式的识别程度较低。当用这些血清检测变性的人蛋白质时,未发现反应性。此外,未糖基化的H1亚基以及任何HepG2合成的去唾液酸糖蛋白受体形式均未与抗体结合。总之,这些结果表明,自身免疫性肝炎患者血清中的抗去唾液酸糖蛋白受体抗体针对的是人类肝脏蛋白成熟异源寡聚体形式的构象结构,并且至少一些表位位于抗原的细胞外结构域。

相似文献

1
Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies.自身抗体识别的去唾液酸糖蛋白受体上抗原位点的研究。
Clin Exp Immunol. 1998 Sep;113(3):339-45. doi: 10.1046/j.1365-2249.1998.00673.x.
2
Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis.自身免疫型慢性肝炎中针对人去唾液酸糖蛋白受体的自身抗体。
Hepatology. 1990 Apr;11(4):606-12. doi: 10.1002/hep.1840110413.
3
Detection of circulating autoantibodies directed against the asialoglycoprotein receptor using recombinant receptor subunit H1.使用重组受体亚基H1检测针对去唾液酸糖蛋白受体的循环自身抗体。
J Immunol Methods. 2005 Jun;301(1-2):1-10. doi: 10.1016/j.jim.2005.01.007. Epub 2005 Feb 17.
4
Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases.通过捕获免疫测定法检测到的抗去唾液酸糖蛋白受体自身抗体与自身免疫性肝病有关。
Acta Med Okayama. 2002 Apr;56(2):99-105. doi: 10.18926/AMO/31695.
5
Virus-induced anti-asialoglycoprotein receptor autoimmunity in experimental hepadnaviral hepatitis.实验性乙型肝炎病毒肝炎中病毒诱导的抗去唾液酸糖蛋白受体自身免疫反应
Hepatology. 1997 Mar;25(3):689-96. doi: 10.1002/hep.510250333.
6
Auto-antibodies to the asialoglycoprotein receptor in sera of children with auto-immune hepatitis.
Eur J Pediatr. 2000 May;159(5):310-3. doi: 10.1007/s004310051278.
7
Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis.自身免疫性肝炎中抗去唾液酸糖蛋白受体自身抗体的人口统计学特征
Gastroenterology. 1994 Sep;107(3):799-804. doi: 10.1016/0016-5085(94)90129-5.
8
The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies.BP180抗原的细胞内和细胞外结构域包含妊娠类天疱疮自身抗体靶向的新表位。
J Invest Dermatol. 2007 Apr;127(4):864-73. doi: 10.1038/sj.jid.5700594. Epub 2006 Oct 19.
9
Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis.2型自身免疫性肝炎中抗肝细胞溶质自身抗体患者的B细胞反应特征
Eur J Immunol. 2003 Jul;33(7):1869-78. doi: 10.1002/eji.200323857.
10
Rabbit anti-HMG-17 antibodies recognize similar epitopes on the HMG-17 molecule as lupus autoantibodies. Relation with histone H1 defined epitopes.兔抗HMG-17抗体识别的HMG-17分子上的表位与狼疮自身抗体识别的表位相似。与组蛋白H1定义的表位的关系。
J Pept Sci. 2002 Dec;8(12):683-94. doi: 10.1002/psc.429.

引用本文的文献

1
Targeting Wnt-β-Catenin Signaling Pathway for Hepatocellular Carcinoma Nanomedicine.靶向Wnt-β-连环蛋白信号通路用于肝癌纳米医学
Gastro Hep Adv. 2023 Jul 20;2(7):948-963. doi: 10.1016/j.gastha.2023.07.012. eCollection 2023.
2
The Emerging Role of Ferroptosis in Various Chronic Liver Diseases: Opportunity or Challenge.铁死亡在各种慢性肝病中的新兴作用:机遇还是挑战
J Inflamm Res. 2023 Jan 31;16:381-389. doi: 10.2147/JIR.S385977. eCollection 2023.
3
Drug delivery strategy in hepatocellular carcinoma therapy.肝癌治疗中的药物输送策略。
Cell Commun Signal. 2022 Mar 5;20(1):26. doi: 10.1186/s12964-021-00796-x.
4
Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity.去唾液酸糖蛋白受体(ASGPR):肝脏特异性自身免疫的独特靶点。
Auto Immun Highlights. 2012 Oct 30;3(3):119-25. doi: 10.1007/s13317-012-0041-4. eCollection 2012 Dec.
5
Autoantibody-negative autoimmune hepatitis.自身抗体阴性自身免疫性肝炎。
Dig Dis Sci. 2012 Mar;57(3):610-24. doi: 10.1007/s10620-011-2017-z. Epub 2011 Dec 21.
6
Autoantibodies as prognostic markers in autoimmune liver disease.自身抗体作为自身免疫性肝病的预后标志物。
Dig Dis Sci. 2010 Aug;55(8):2144-61. doi: 10.1007/s10620-010-1268-4. Epub 2010 May 13.
7
Treatment of Autoimmune Hepatitis: Current and Future Therapies.自身免疫性肝炎的治疗:当前与未来的疗法
Curr Treat Options Gastroenterol. 2004 Oct;7(5):413-420. doi: 10.1007/s11938-004-0054-9.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Preparation of iodine-131 labelled human growth hormone of high specific activity.高比活度碘-131标记人生长激素的制备
Nature. 1962 May 5;194:495-6. doi: 10.1038/194495a0.
3
Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis.
Dig Dis Sci. 1996 Sep;41(9):1733-40. doi: 10.1007/BF02088738.
4
Intracellular retention and degradation of human mutant variant of a alpha 1-antitrypsin in stably transfected Chinese hamster ovary cell lines.人α1-抗胰蛋白酶突变体在稳定转染的中国仓鼠卵巢细胞系中的细胞内滞留与降解
Eur J Biochem. 1993 Apr 1;213(1):271-6. doi: 10.1111/j.1432-1033.1993.tb17759.x.
5
Meeting report: International Autoimmune Hepatitis Group.会议报告:国际自身免疫性肝炎小组
Hepatology. 1993 Oct;18(4):998-1005. doi: 10.1002/hep.1840180435.
6
High-yield purification and characterization of human asialoglycoprotein receptor.人去唾液酸糖蛋白受体的高效纯化与表征
Protein Expr Purif. 1995 Jun;6(3):251-5. doi: 10.1006/prep.1995.1032.
7
The asialoglycoprotein receptor: relationships between structure, function, and expression.去唾液酸糖蛋白受体:结构、功能与表达之间的关系
Physiol Rev. 1995 Jul;75(3):591-609. doi: 10.1152/physrev.1995.75.3.591.
8
The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins.一种对去唾液酸糖蛋白具有特异性的兔肝结合蛋白的分离及特性
J Biol Chem. 1974 Sep 10;249(17):5536-43.
9
Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum.抗肝肾微粒体抗体识别内质网中一种分子量为50,000的蛋白质。
J Exp Med. 1985 May 1;161(5):1231-6. doi: 10.1084/jem.161.5.1231.
10
Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders.
J Hepatol. 1986;3(2):196-205. doi: 10.1016/s0168-8278(86)80026-5.